Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Every 8-K item filed, including the routine ones - earnings dates, shareholder votes and Regulation FD disclosures. Not the exhibit lists.

Date Company Event Filing
American Outdoor Brands, Inc. AOUT Regulation FD disclosure Item 7.01 Form 8-K
Amphastar Pharmaceuticals, Inc. AMPH Results announced Item 2.02 Form 8-K
Amrize Ltd AMRZ Results announced Item 2.02 Form 8-K
Amrize Ltd AMRZ Regulation FD disclosure Item 7.01 Form 8-K
Amylyx Pharmaceuticals, Inc. AMLX Results announced Item 2.02 Form 8-K
Annexon, Inc. ANNX Other event Item 8.01 Form 8-K
Anterix Inc. ATEX Officer or director change Item 5.02 Form 8-K
Anterix Inc. ATEX Shareholder vote Item 5.07 Form 8-K
Apimeds Pharmaceuticals US, Inc. APUS Other event Item 8.01 Form 8-K
Apple Hospitality REIT, Inc. APLE Other event Item 8.01 Form 8-K
Apyx Medical Corp APYX Results announced Item 2.02 Form 8-K
Arcturus Therapeutics Holdings Inc. ARCT Results announced Item 2.02 Form 8-K
Arhaus, Inc. ARHS Results announced Item 2.02 Form 8-K
Arhaus, Inc. ARHS Regulation FD disclosure Item 7.01 Form 8-K
Arlo Technologies, Inc. ARLO Results announced Item 2.02 Form 8-K
Arteris, Inc. AIP Results announced Item 2.02 Form 8-K
Arteris, Inc. AIP Officer or director change Item 5.02 Form 8-K
Arteris, Inc. AIP Regulation FD disclosure Item 7.01 Form 8-K
Artiva Biotherapeutics, Inc. ARTV Results announced Item 2.02 Form 8-K
Astrana Health, Inc. ASTH Results announced Item 2.02 Form 8-K
Astrana Health, Inc. ASTH Regulation FD disclosure Item 7.01 Form 8-K
Atlantic Union Bankshares Corp AUB Regulation FD disclosure Item 7.01 Form 8-K
Atlassian Corp TEAM Results announced Item 2.02 Form 8-K
Atlassian Corp TEAM Other event Item 8.01 Form 8-K
Attovia Therapeutics, Inc. ATTO Charter or fiscal year changed Item 5.03 Form 8-K
Aurinia Pharmaceuticals Inc. AUPH Results announced Item 2.02 Form 8-K
Avalo Therapeutics, Inc. AVTX Results announced Item 2.02 Form 8-K
AvePoint, Inc. AVPT Results announced Item 2.02 Form 8-K
Axos Financial, Inc. AX Regulation FD disclosure Item 7.01 Form 8-K
BECTON DICKINSON & CO BDX Results announced Item 2.02 Form 8-K
BENTLEY SYSTEMS INC BSY Results announced Item 2.02 Form 8-K
BIOLIFE SOLUTIONS INC BLFS Results announced Item 2.02 Form 8-K
BIOMARIN PHARMACEUTICAL INC BMRN Results announced Item 2.02 Form 8-K
BIOVIE INC. BIVI Regulation FD disclosure Item 7.01 Form 8-K
BKV Corp BKV Results announced Item 2.02 Form 8-K
BKV Corp BKV Results announced Item 2.02 Form 8-K
BKV Corp BKV Regulation FD disclosure Item 7.01 Form 8-K
BKV Corp BKV Regulation FD disclosure Item 7.01 Form 8-K
BRADY CORP BRC Material agreement signed Item 1.01 Form 8-K
BRADY CORP BRC Acquisition or disposal completed Item 2.01 Form 8-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.